Canary Speech, a Provo, UT-based AI-powered voice biomarker health tech company, raised $13m in Series A funding.
The round was led by Cortes Capital (Love’s Private Equity), with participation from Sorenson Communications, SMK, and Hackensack Meridian Health.
The company intends to use the funds to expand its team to support growth driven by advancements in artificial intelligence and the healthcare industry’s demand for more advanced tools.
Led by CEO Henry O’Connell, Canary Speech is an AI-powered voice biomarker health tech company that uses real-time patented vocal analysis to screen for mental health and neurological disorders. Its technology captures and analyzes speech data within seconds to identify irregularities in behavioral and cognitive changes before current clinical screening standards or noticeable symptoms for invisible illnesses like anxiety, depression and dementia.
As an API-first company, Canary’s vocal biomarker technology has a wide range of applications within the healthcare industry. These applications include contact centers, ambient clinical listening, remote patient monitoring, and annual wellness checks. Ambient listening tools, which are systems designed to unobtrusively capture and analyze conversations in real-time, enable healthcare providers to focus on patient interactions while automatically documenting clinical notes.
FinSMEs
12/06/2024